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The Centers for Disease Control and Prevention (CDC) has
estimated that health care-associated infections account for an
estimated 1.7 million infections, 99,000 deaths, and $4.5 billion
in excess health care costs annually (16). The key interventions
used to control health care-associated infections include sur-
veillance (27, 33), isolation of patients with communicable
diseases (26) or multidrug-resistant pathogens (81), proper
skin antisepsis prior to invasive procedures and hand hygiene
by health care workers (12), and appropriate disinfection and
sterilization of medical devices and environmental surfaces
(73, 75, 79).
Multiple nosocomial outbreaks have resulted from inade-
quate antisepsis or disinfection. Inadequate skin antisepsis may
result from a lack of intrinsic antimicrobial activity of the
antiseptic, a resistant pathogen, overdilution of the antiseptic,
or the use of a contaminated antiseptic. The inadequate dis-
infection of medical devices or environmental surfaces may
result from a lack of intrinsic antimicrobial activity of the
disinfectant, an incorrect choice of a disinfectant, a resistant
pathogen, overdilution of the disinfectant, an inadequate du-
ration of disinfection, a lack of contact between the disinfec-
tant and the microbes, or the use of a contaminated disinfec-
tant. Editorials have noted that contaminated antiseptics and
disinfectants have been the occasional vehicles of hospital in-
fections for more than 50 years (20, 72, 76). This paper con-
cisely reviews nosocomial outbreaks associated with the use of
a microbiologically contaminated germicide and focuses on the
currently recommended germicides.
DEFINITIONS
A precise understanding of terminology is important to un-
derstanding the uses of germicides in modern health care.
Germicides are biocidal agents that inactivate microorganisms
and include antiseptics, disinfectants, and preservatives. Anti-
septics are antimicrobial substances that are applied to the skin
or mucous membranes to reduce the microbial flora. Disinfec-
tants are substances that are applied to inanimate objects to
destroy harmful microorganisms, although they may not kill
bacterial spores. Decontamination is a procedure that removes
pathogenic microorganisms from objects so they are safe to
handle, use, or discard. Finally, preservatives are incorporated
into medications or fluids to prevent microbial growth. Ger-
micides may become contaminated as a result of improper
manufacturing techniques or during shipping (intrinsic con-
tamination) or during manipulation or use within the health
care facility (extrinsic contamination).
Disinfectants are further categorized by their degree of ef-
fectiveness (73, 75). The choice of disinfectant agent is based
on the intended use of the patient care item (Table 1).
MICROBIAL RESISTANCE TO GERMICIDES
Microbial resistance to germicides has been reviewed previ-
ously (37, 49, 62, 68, 71). As with antibiotic resistance, resis-
tance to germicides may be an intrinsic property or may arise
either by chromosomal gene mutation or by the acquisition of
genetic material in the form of plasmids or transposons (49, 68,
71). Importantly, although microbes may display intrinsic re-
sistance to specific antiseptics, antibiotic-resistant pathogens
(e.g., methicillin-resistant Staphylococcus aureus and vancomy-
cin-resistant enterococci) do not demonstrate resistance to
germicides at the currently used contact times and concentra-
tions (29, 66, 67, 69, 70, 92).
ANTISEPTICS
Antiseptics are used in health care to reduce the transient
microbial flora on the hands of health care providers, to reduce
the person-to-person transmission of microbes (e.g., methicil-
lin-resistant Staphylococcus aureus), to prepare the skin of pa-
tients prior to invasive procedures, and to achieve surgical
hand antisepsis. The products commonly used in the United
States include alcohols, chlorhexidine, chloroxylenol, iodine
and iodophors, quaternary ammonium compounds (e.g., ben-
zethonium chloride), and triclosan (12). The antimicrobial
spectra of the currently used antiseptics are displayed in Table
2. More than 40 outbreaks and pseudo-outbreaks due to con-
taminated antiseptics have been reported (Table 3) (4, 5, 8, 10,
11, 13–15, 17, 19, 20, 24, 25, 28, 30, 32, 34, 36, 38, 39, 43, 45–47,
50, 52–54, 58, 59, 61, 63, 78, 83–86, 89–91, 93).
Alcohols. The majority of alcohol-based hand antiseptics
contain isopropanol, ethanol, or N-propanol. The latter agent,
N-propanol, is not currently approved for use for hand hygiene
in the United States. Antiseptic agents are available that com-
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bine two alcohols or alcohol solutions and another agent (e.g.,
hexachlorophene, quaternary ammonium compounds, povi-
done-iodine, triclosan, or chlorhexidine gluconate). Waterless
alcohol foams, liquids, and gels are now widely used in health
care to improve compliance with hand hygiene (35, 60, 65).
Importantly, alcohols have poor activity against bacterial
spores, protozoan oocysts, and certain nonlipophilic (nonen-
veloped) viruses.
The contamination of alcohol-based solutions has rarely
been reported. One pseudoepidemic of bacteremia (34) and
one outbreak of bacteremia (54) have been traced to contam-
inated alcohol used for skin antisepsis. These were traced to
the use of intrinsically contaminated alcohol (34) and dilution
of the alcohol with contaminated water (54).
Chlorhexidine. Chlorhexidine gluconate is widely used in
the United States for hand hygiene. Its antimicrobial activity
occurs more slowly than that of alcohols.
Multiple outbreaks have been linked to contaminated chlor-
hexidine. Most reports have been traced to the use of contam-
inated water to prepare diluted preparations and/or the prac-
tice of reusing bottles to dispense chlorhexidine without
adequate disinfection. Although most outbreaks have occurred
with solutions containing less than 2% chlorhexidine, an out-
break has been reported with solutions of 2% to 4% chlor-
TABLE 1. Classification and uses of chemical disinfectantsa
Disinfection process Level of microbial inactivation Agents Health care uses
High-level (liquid immersion) Destroys all microorganisms
except high numbers of
bacterial spores
2% glutaraldehyde (20–45 min), 0.55%
ortho-phthalaldehyde (12 min), 1.12%
glutaraldehyde and 1.93% phenol (20
min), 7.35% hydrogen peroxide and
0.23% peracetic acid (15 min), 7.5%
hydrogen peroxide (30 min), 1.0%
hydrogen peroxide and 0.08%
peracetic acid (25 min), and 650–675












most viruses, and most
fungi but not bacterial
spores
EPA-registered hospital disinfectants
with label claiming tuberculocidal
activity, such as chlorine-based
products and phenolics (60 s)
Noncritical patient care
items (blood pressure
cuffs) or surfaces (bed
rails) with visible blood
Low-level (liquid contact) Destroys vegetative bacteria




with no tuberculocidal claim, such as
chlorine-based products, phenolics,
and quarternary ammonium




cuffs) or surfaces (bed
rails) with no visible
blood
a Data are from reference 75.
TABLE 2. Antimicrobial spectrum and characteristics of hand hygiene antiseptic agentsa
Group
Activity againstb:
Speed of action CommentsGram-positive
bacteria
Gram-negative
bacteria Mycobacteria Fungi Viruses





     Intermediate Persistent activity; rare
allergic reactions
Iodine compounds      Intermediate Causes skin burns;
usually too irritating
for hand hygiene
Iodophors      Intermediate Less irritating than
iodine; acceptance
varies
Phenol derivatives      Intermediate Activity neutralized by
nonionic surfactants








a Data are from reference 12. Information for hexachlorophene is not included because it is no longer an accepted ingredient of hand disinfectants.
b , excellent; , good but does not include entire microbial spectrum; , fair; , no activity or not sufficient.
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TABLE 3. Outbreaks and pseudo-outbreaks due to contaminated antiseptics
Antiseptic Contaminant(s) Site(s) of microbes Mechanism of contamination/source Author(s), yr (reference)
Alcohols Bacillus cereus Blood (pseudobacteremia),
pleural fluid
Intrinsic contamination Hsueh et al., 1999 (34)
Alcohols Burkholderia cepacia Blood (catheter related) Contaminated tap water used to
dilute alcohol for skin
antisepsis
Nasser et al., 2004 (54)
Chlorhexidine Pseudomonas spp. Not stated Refilling contaminated bottles;
washing used bottles using





Chlorhexidine Burkholderia cepacia Blood, urinary, wounds Not determined Speller et al., 1971 (84)
Chlorhexidine Flavobacterium
meningosepticum
Blood, CSF,a wounds, skin Not determined but possibly due
to contaminated water and/or





Chlorhexidine Pseudomonas sp., Serratia
marcescens, Flavobacterium
sp.
Not stated Not determined, but authors
speculate due to overdilution




Chlorhexidine Pseudomonas aeruginosa Wounds Tap water used to dilute stock
solutions; low concentration
(0.05%)
Anyiwo et al., 1982 (4)
Chlorhexidine Bulkholderia cepacia Blood, wounds, urine,
mouth, vagina
Metal pipe and rubber tubing in
pharmacy through which
deionized water passed during
dilution of chlorhexidine; low
concentration
Sobel et al., 1982 (83)
Chlorhexidine Ralstonia pickettii Blood Contaminated bidistilled water
used to dilute chlorhexidine;
low concentration (0.05%)
Kahan et al., 1983 (38)
Chlorhexidine Ralstonia pickettii Blood Contaminated deionized water;
low concentration (0.05%)
Poty et al., 1987 (63)





Chlorhexidine Ralstonia pickettii Blood (pseudobacteremia) Distilled water used to dilute
chlorhexidine; low
concentration (0.05%)
Maroye et al., 2000 (46)
Chlorhexidine Achromobacter xylosoxidans Blood, wounds Atomizer (low concentration,
600 mg/liter)
Vu-Thien et al., 1998
(91)
Chlorhexidine Achromobacter xylosoxidans Blood Atomizer Tena et al., 2005 (85)
Chlorhexidine Serratia marcescens Bood, urine, wounds,
sputum, others
Not determined, but use of
nonsterile water for dilution to
2% and distribution in
reusable nonsterile containers
Vigeant et al., 1998 (90)
Chlorhexidine plus
cetrimide







Stenotrophomonas maltophilia Urine, umbilical swabs,
catheter tips, others
Deionized water used to prepare
solutions; failure to disinfect
contaminated bottles between
use
Wishart and Riley, 1976
(93)
Chloroxylenol Serratia marcescens Multiple sites Contaminated (extrinsic) 1%
chloroxylenol soap; sink




Pseudomonas species Blood Storage of benzalkonium








Blood, urine Storage of benzalkonium
chloride (0.1%) with cotton/
gauze; dilution with nonsterile
water




Enterobacter aerogenes Blood, sinus tract Storage of benzalkonium
chloride (0.13%) with cotton/
gauze
Malizia et al., 1960 (45)
Benzalkonium
chloride
Pseudomonas kingii Urine Contamination (intrinsic) of
antiseptic
CDC, 1969 (15)
Continued on following page
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hexidine (90). The inappropriate use of chlorhexidine as a
disinfectant has also led to outbreaks. Examples include the
use of contaminated chlorhexidine solutions to disinfect glass
reservoirs containing urinary bladder irrigants (51), plastic
clamps (48), and thermometers (17). Outbreaks due to con-
taminated chlorhexidine/cetrimide solutions have also been
reported (8, 13, 93).
Chloroxylenol. Chloroxylenol, also known as parachloro-
metaxylenol, is a halogen-substituted phenolic compound that
has been used both as a preservative and as an active agent in
antimicrobial soaps. An outbreak of Serratia marcescens infec-
tion or colonization in a neonatal intensive care unit was traced
to extrinsically contaminated 1% chloroxylenol soap (5).
Quaternary ammonium compounds. Quaternary ammo-
nium compounds are composed of a nitrogen atom linked
directly to four alkyl groups, which may vary in their structure
and complexity. Of this large group of compounds, alkyl ben-
zalkonium chlorides are the most widely used as antiseptics.
Other agents include benzethonium chloride, cetrimide, and
cetylpyridium chloride. The FDA classifies benzalkonium chlo-
ride as having insufficient data to classify it as safe and effective
for use for antiseptic hygiene.
More outbreaks have been ascribed to contaminated benza-
lkonium chloride than any other antiseptic (Table 3). In 2003,
Tiwari and colleagues reviewed the literature and referenced
multiple reports of outbreaks or pseudo-outbreaks associated
with the use of benzalkonium chloride (86). The most common
species were aerobic, gram-negative bacilli, including Burk-
holderia cepacia, S. marcescens, and Enterobacter spp. Most but
not all outbreaks were linked to the storage of benzalkonium
chloride with cotton or gauze or the improper dilution of the
benzalkonium chloride solution. The use of benzalkonium
TABLE 3—Continued
Antiseptic Contaminant(s) Site(s) of microbes Mechanism of contamination/source Author(s), yr (reference)
Benzalkonium
chloride
Pseudomonas EO-1 Urine Contaminated (intrinsic)
cleansing-germicide solution
Hardy et al., 1970 (32)
Benzethonium
chloride
Pseudomonas species Blood (pseudobacteremia) Contaminated (intrinsic solution;
0.2%)









Kaslow et al., 1976 (39)
Benzalkonium
chloride
Bulkholderia cepacia Bacteremia Storage of benzalkonium
chloride with rayon balls;






Serratia marcescens Intravenous catheters
(dogs and cats), other
sites
Storage of benzalkonium
chloride (0.025%) with cotton/
gauze
Fox et al., 1981 (24)
Benzalkonium
chloride
Serratia marcescens Joint Storage of benzalkonium
chloride with cotton/gauze




Serratia marcescens CSF Contamination (extrinsic) of
stock bottle
Sautter et al., 1984 (78)
Benzalkonium
chloride
















Burkholderia cepacia Blood, urine, wound,
sputum







Burkholderia cepacia Blood Water used to dilute the
antiseptic
Morris et al., 1976 (52)
Povidone-iodine Burkholderia cepacia Blood (pseudobacteremia) Intrinsic contamination 10%
povidone-iodine (probable
B. cepacia proliferating on the
deionizing resin in the water
system)
Berkelman et al., 1981
(10)
Povidone-iodine Burkholderia cepacia Blood (pseudobacteremia) Intrinsic contamination Craven et al., 1981 (19)
Poloxamer-iodine Pseudomonas aeruginosa Peritoneal fluid, wound Intrinsic contamination Parrott et al., 1982 (59)
Povidone-iodine Burkholderia cepacia Blood (pseudobacteremia),
peritoneal fluid
Intrinsic contamination CDC, 1989 (14); Jarvis,
1991 (36); Panlilio
et al., 1992 (58)
Povidone-iodine Pseudomonas putida Blood, catheter tips Not determined Bouallègue et al., 2004
(11)
Triclosan Serratia marcescens Conjunctiva Intrinsic contamination McNaughton et al.,
1995 (50)
a CSF, cerebrospinal fluid.
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chloride to disinfect endoscopes has also led to urinary tract
and pulmonary infections (20), and the use of contaminated
spray bottles for environmental disinfection led to S. marc-
escens infections complicating cardiopulmonary surgery (22).
The failure of benzalkonium chloride as a preservative in mul-
tidose albuterol bottles led to respiratory tract colonization
and infection (31). Contaminated benzalkonium chloride used
to disinfect the septa of multidose corticosteroid bottles has led
to injection site abscesses with Pseudomonas aeruginosa (56).
Iodine and iodophors. Iodine has been used as an antiseptic
for more than 100 years. Because iodine often causes irritation
and discoloring of the skin, iodophors have largely replaced
iodine as the active agent in antiseptics. Multiple outbreaks
due to contaminated iodophors have been reported (Table 3).
The prolonged survival of B. cepacia in commercially manu-
factured providone-iodine has been documented (3), and in-
trinsic contamination of a povidone-iodine solution led to both
infections and pseudoinfections (10, 14, 36, 58–59). These re-
ports of intrinsic microbial contamination of antiseptic formu-
lations of povidone-iodine and poloxamer-iodine caused a re-
appraisal of the chemistry and use of iodophors. It was found
that “free” iodine (I2) contributes to the bactericidal activity of
iodophors and that dilutions of iodophors demonstrate more
rapid bactericidal action than a full-strength povidone-iodine
solution. The reason for the observation that dilution increases
bactericidal activity is unclear, but it has been suggested that
dilution of povidone-iodine results in a weakening of the io-
dine linkage to the carrier polymer, with an accompanying
increase of free iodine in solution. Therefore, iodophors must
be diluted according to the manufacturers’ directions to
achieve antimicrobial activity.
Although most reports of contaminated iodophors have re-
ported contamination with gram-negative bacilli, O’Rourke
and colleagues isolated Staphylococcus aureus from the rims of
two bottles containing an iodophor in an operating room (57).
No infections were noted as a result of this contamination.
Triclosan. Triclosan at concentrations of 0.2% to 2% has
antimicrobial activity and has been incorporated into soaps for
use by health care workers and into a variety of commercial
products. It has a broad range of antimicrobial activity, but it is
often bacteriostatic.
Liquid soap bottles containing 1% triclosan used as an op-
erating room scrub were found to be contaminated with S.
marcescens or Candida parapsilosis (7). However, no infections
were reported. An outbreak of newborn conjunctivitis due to S.
marcescens was associated with the use of intrinsically contam-
inated 0.5% triclosan antiseptic soap (50).
DISINFECTANTS
A variety of chemical agents are used as disinfectants; the
choice of an agent depends on its intended use (Table 1).
Disinfectants have not been as commonly involved in out-
breaks as antiseptics (Table 4) (6, 9, 18, 20–23, 41, 42, 44, 55,
56, 64, 80, 82, 87, 88). The agents currently approved for use as
high-level disinfectants (e.g., chlorine, peracetic acid, and or-
tho-phthalaldehyde) have rarely, if ever, been implicated in
outbreaks. However, outbreaks may occur when ineffective
disinfectants, including iodophors, alcohols, and overdiluted
glutaraldehyde, are used for high-level disinfection.
Alcohols. Alcohol is widely used for the environmental dis-
infection of small areas (i.e., “spot” disinfection). Flammability
precludes its use on large surfaces. Multiple outbreaks have
resulted from the use of alcohols as “high-level” disinfectants
for semicritical medical devices. Rarely, contaminated alcohol
used as a surface disinfectant has been linked to outbreaks. For
example, Berger reported an epidemic of pseudobacteremia
with Bacillus cereus that was traced to contaminated cotton
pads maintained in 70 to 90% ethanol that were used to dis-
infect the top of blood culture bottles before inoculation (9).
Alcohol is not effective as a surface disinfectant against ade-
novirus, and its use to disinfect tonometer tips has been asso-
ciated with epidemic keratoconjunctivitis (40).
Glutaraldehyde. The biocidal activity of glutaraldehyde is a
consequence of its alkylation of the sulfydryl, hydroxy, carboxyl,
and amino groups of microorganisms, which alters RNA, DNA,
and protein synthesis. There have been reports of microorganisms
with resistance to glutaraldehyde, including some mycobacteria
(e.g., Mycobacterium chelonae and Mycobacterium xenopi), Methylo-
bacterium mesephilicum, Trichosporon, fungal ascospores, and
Cryptosporidium (73). A pseudo-outbreak caused by Mycobacte-
rium chelonae and Methylobacterium mesophilicum due to con-
tamination of an automated endoscope washer was reported (41).
M. chelonae grew from the endoscopes, the automated washers,
and the glutaraldehyde from the washers.
Quaternary ammonium compounds. The bactericidal action
of the quaternary ammonium compounds has been attributed
to the inactivation of energy-producing enzymes, denaturation
of essential cell proteins, and disruption of the cell membrane.
A pseudo-outbreak of B. cepacia bacteremia was traced to the
use of a contaminated quaternary ammonium compound to
disinfect the rubber stoppers of blood culture bottles (21).
Formaldehyde. Formaldehyde inactivates microorganisms
by alkylating the amino and sulfhydryl groups of proteins and
the ring nitrogen atoms of purine bases. The aqueous solution
TABLE 4. Reports of contaminated disinfectants
Disinfectant Contaminating microbes (reference)
Ethanol ...........................................................................Bacillus cereus (9)a
Glutaraldehyde ..............................................................Mycobacterium chelonae (41),a Methylobacterium mesophilicum (41),a Mycobacterium species
(42, 87)
Formaldehyde ................................................................Pseudomonas aeruginosa (88),a Stenotrophomonas maltophilia (88), Klebsiella oxytoca (64)a
Quaternary ammonium compounds............................Burkholderia cepacia (20, 21),a Serratia marcescens (22),a Achromobacter xylosoxydans (44),a
Pseudomonas aeruginosa (56, 80)a
Phenolics.........................................................................Pseudomonas species (18, 23, 55), Pseudomonas aeruginosa (6,a 55), Alcaligenes faecalis (82)
a Outbreak or pseudo-outbreak.
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is virucidal, bactericidal, tuberculocidal, fungicidal, and spori-
cidal. An outbreak of Klebsiella oxytoca sepsis in a neonatal and
pediatric intensive care unit was traced to a contaminated
solution of formaldehyde (8.0 g/dl) used for disinfection of
surfaces and infusion pumps (64), while an outbreak of Pseudo-
monas sepsis due to deficient formaldehyde mixing used to
disinfect dialyzers was reported (88).
Phenolics. The contamination of phenolics used for disin-
fection has been reported previously (Table 4).
DISCUSSION
Outbreaks and pseudo-outbreaks related to contaminated
germicides have most commonly been reported with contam-
inated antiseptics. Outbreaks from contaminated high-level
disinfectants have rarely, if ever, been reported. Outbreaks
from contaminated intermediate- and low-level disinfectants
have occasionally been reported. All outbreaks associated with
contaminated germicides have occurred due to gram-negative
bacilli or mycobacteria. This is felt to be due to the fact that the
outer membrane of gram-negative bacteria or the complex cell
wall of mycobacteria acts as a barrier to germicides (49).
Both outbreaks and sporadic failures of germicides may be
due to user error rather than microbial contamination. Com-
mon errors include the use of overdiluted solutions, the use of
outdated products, the use of tap water to dilute the germicide,
the refilling of small-volume dispensers from large-volume
stock containers, and the improper selection of an appropriate
product (e.g., the use of a low-level disinfectant rather than a
high-level disinfectant to disinfect an endoscope). Because
multiple outbreaks have resulted from the refilling of small-
volume dispensers from large-volume stock containers, small-
volume containers should be used until they are completely
empty (i.e., do not “top off” the containers), rinsed with tap
water, and then air dried before they are refilled. When a
potential failure of proper disinfection or sterilization occurs,
we recommend the use of a standardized risk assessment for
determining patient risk and the need to inform patients (74).
A critical component of disinfection is prior cleaning. Prior
cleaning is necessary to remove proteinaceous material and
biofilms to allow the germicide to achieve adequate microbial
inactivation. Experimental studies have demonstrated that the
physical thickness of the cellular and extracellular material that
forms on surfaces (i.e., biofilms) can protect imbedded organ-
isms from the microbicidal actions of disinfectants and anti-
septics (1, 2). For example, the bacteria growing in a biofilm
can be up to 1,500 times more resistant to germicides than the
same bacteria growing in liquid culture (77). The failure to
properly clean medical devices may lead to inadequate micro-
bial inactivation for all chemical germicides.
With the use of more effective agents and newer guidelines,
the number of outbreaks due to contaminated germicides had
decreased over the past 50 years. However, in order to prevent
future outbreaks associated with contaminated germicides, it is
critical to follow the standard recommendations, which are as
follows: (i) use only CDC-recommended and FDA-cleared
antiseptics; (ii) use only CDC-recommended and EPA-regis-
tered or FDA-cleared disinfectants; (iii) use all germicides at
their recommended use dilution, and do not overdilute prod-
ucts; (iv) use sterile water to dilute antiseptics; (v) use all
germicides for the recommended contact times; (vi) do not use
germicides labeled only as antiseptics for the disinfection of
medical devices or surface disinfection; (vii) follow the recom-
mended procedures in the preparation of products to prevent
extrinsic contamination; (viii) small-volume dispensers that are
refilled from large-volume stock containers should be used
until they are entirely empty, and then they should be rinsed
with tap water and air dried before they are refilled; and (ix)
store stock solutions of germicides as indicated on the product
label.
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